The Papillomavirus E8/\E2C Protein Represses DNA Replication from Extrachromosomal Origins

Molecular and Cellular Biology

Volumn 23, Issue 22, 2003, Pages 8352-8362

  Zobel, Thomas ^a   Iftner, Thomas ^a   Stubenrauch, Frank ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EXTRACHROMOSOMAL DNA; LYSINE; PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR GAL4; TRYPTOPHAN; UNCLASSIFIED DRUG; VIRUS E8 E2C PROTEIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARCINOGENESIS; CELL DIVISION; CONTROLLED STUDY; DIMERIZATION; DNA REPLICATION; DNA SEQUENCE; DNA TUMOR VIRUS; DNA VIRUS; DRUG DESIGN; EPSTEIN BARR VIRUS; GENE REPRESSION; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; PAPILLOMA VIRUS; PLASMID; PRIORITY JOURNAL; PROTEIN DNA BINDING; VIRUS GENOME; VIRUS INFECTION; VIRUS MUTANT;

BASE SEQUENCE; CELL LINE; CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; DNA-BINDING PROTEINS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MUTATION; PAPILLOMAVIRIDAE; PHENOTYPE; PLASMIDS; RECOMBINANT FUSION PROTEINS; REPLICATION ORIGIN; REPRESSOR PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4; PAPILLOMAVIRUS; PROKARYOTA;

EID: 0242663917     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.22.8352-8362.2003     Document Type: Article

References (43)

1. Adams, A. 1987. Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61:1743-1746.
2. Barsoum, J., S. S. Prakash, P. Han, and E. J. Androphy. 1992. Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J. Virol. 66:3941-3945.
3. Bedell, M. A., J. B. Hudson, T. R. Golub, M. E. Turyk, M. Hosken, G. D. Wilbanks, and L. A. Laimins. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
4. Bouvard, V., A. Storey, D. Pim, and L. Banks. 1994. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and transrepression in cervical keratinocytes. EMBO J. 13:5451-5459.
5. Chaudhuri, B., H. Xu, I. Todorov, A. Dutta, and J. L Yates. 2001. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 98:10085-10089.
6. Choe, J., P. Vaillancourt, A. Stenlund, and M. Botchan. 1989. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 63:1743-1755.
7. Demeret, C., M. Le Moal, M. Yaniv, and F. Thierry. 1995. Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic Acids Res. 23:4777-4784.
8. Dhar, S. K., K. Yoshida, Y. Machida, P. Khaira, B. Chaudhuri, J. A. Wohlschlegel, M. Leffak, J. Yates, and A. Dutta. 2001. Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106:287-296.
9. Frattini, M. G., and L. A. Laimins. 1994. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 204:799-804.
10. Gilbert, D. M., and S. N. Cohen. 1987. Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell 50:59-68.
11. Grasser, F. A., P. G. Murray, E. Kremmer, K. Klein, K. Remberger, W. Felden, G. Reynolds, G. Niedobitek, L. S. Young, and N. Mueller-Lantzsch. 1994. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84:3792-3798.
12. Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427-433.
13. Herbig, U., K. Weisshart, P. Taneja, and E. Fanning. 1999. Interaction of the transcription factor TFIID with simian virus 40 (SV40) large T antigen interferes with replication of SV40 DNA in vitro. J. Virol. 73:1099-1107.
14. Lambert, P. F., B. C. Monk, and P. M. Howley. 1990. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants. J. Virol. 64:950-956.
15. Lambert, P. F., B. A. Spalholz, and P. M. Howley. 1987. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell 50:69-78.
16. Law, M. F., D. R. Lowy, I. Dvoretzky, and P. M. Howley. 1981. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc. Natl. Acad. Sci. USA 78:2727-2731.
17. Lee, K.-Y., T. R. Broker, and L. T. Chow. 1998. Transcription factor YY1 represses cell-free replication from human papillomavirus origins. J. Virol. 72:4911-4917.
18. Leight, E. R., and B. Sugden. 2000. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10:83-100.
19. Lepik, D., and M. Ustav. 2000. Cell-specific modulation of papovavirus replication by tumor suppressor protein p53. J. Virol. 74:4688-4697.
20. Li, R., and M. R. Botchan. 1994. Acidic transcription factors alleviate nuclcosome-mediated repression of DNA replication of bovine papillomavirus type 1. Proc. Natl. Acad. Sci. USA 91:7051-7055.
21. Lim, D. A., M. Gossen, C. W. Lehman, and M. R. Botchan. 1998. Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control. J. Virol. 72:1931-1940.
22. McBride, A. A., J. C. Byrne, and P. M. Howley. 1989. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc. Natl. Acad. Sci. USA 86:510-514.
23. McBride, A. A., H. Romanczuk, and P. M. Howley. 1991. The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266:18411-18414.
24. Melendy, T., and R. Li. 2001. Chromatin remodeling and initiation of DNA replication. Front. Biosci. 6:D1048-D1053.
25. Miller, S. D., G. Farmer, and C. Prives. 1995. p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner. Mol. Cell. Biol. 15:6554-6560.
26. Murakami, Y., and Y. Ito. 1999. Transcription factors in DNA replication. Front. Biosci. 4:D824-D833.
27. Remm, M., R. Brain, and J. R. Jenkins. 1992. The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res. 20:6015-6021.
28. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
29. Riese, D. J., II, J. Settleman, K. Neary, and D. DiMaio. 1990. Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity. J. Virol. 64:944-949.
30. Russell, J., and M. R. Botchan. 1995. cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin. J. Virol. 69:651-660.
31. Schepers, A., M. Ritzi, K. Bousset, E. Kremmer, J. L. Yates, J. Harwood, J. F. Diffley, and W. Hammerschmidt. 2001. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20:4588-4602.
32. Stenlund, A. 1996. Papillomavirus DNA replication, p. 679-698. In M. De-Pamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Stubenrauch, F., A. M. E. Colbert, and L. A. Laimins. 1998. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J. Virol. 72:8115-8123.
34. Stubenrauch, F., M. Hummel, T. Iftner, and L. A. Laimins. 2000. The E8/E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J. Virol. 74:1178-1186.
35. Stubenrauch, F., H. B. Lim, and L. A. Laimins. 1998. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol. 72:1071-1077.
36. Stubenrauch, F., T. Zobel, and T. Iftner. 2001. The E8 domain confers a novel long-distance transcriptional repression activity on the E8/E2C protein of high-risk human papillomavirus type 31. J. Virol. 75:4139-4149.
37. Ustav, M., E. Ustav, P. Szymanski, and A. Stenlund. 1991. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10:4321-4329.
38. Yang, L., R. Li, I. J. Mohr, R. Clark, and M. R. Botchan. 1991. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353:628-632.
39. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
40. Yates, J. L., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483-488.
41. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-815.
42. zur Hausen, H. 1994. Human pathogenic papillomaviruses, p. 131-156. Springer-Verlag KG, Berlin, Germany.
43. zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.